Anita Howe, Ph.D. British Columbia Centre for Disease Control, Vancouver, Canada (SHARED coordinator).
Naveed Janjua, Ph.D. British Columbia Centre for Disease Control, Vancouver, Canada.
Federico García, Pharm D., Ph.D. Servicio de Microbiología Hospital Universitario San Cecilio, Av. de la Innovación S/N 18016; Granada, Spain (HepCare).
Jean-Michel Pawlotsky, MD, Ph.D. Hopital Henri Mondor, Universite Paris Est, 51 avenue du Marechal de Lattre de Tassigny, 94010 CRETEIL, FRANCE.
Francesca Ceccherini-Silberstein, Ph.D. Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Via Montpellier 1, Rome 00133, Italy (HepCare).
Richard Harrigan, Ph.D. Research Labs, Interim Head, Division of AIDS, Department of Medicine, University of BC 2775 Laurel Street, 10th Floor. Vancouver BC CANADA V6T 1Z3
Jordan Feld, MD. (CanHep C ) Toronto Western Hospital Liver Center. University Health Network. McLauglin-Rotman Centre for Global Health.
Andrew Lloyd, Ph.D. Viral Immunology Systems Program. The Kirby Institute, UNSW Sydney. Wallace Wurth Building, Sydney, NSW, 2052 Australia.
Alnoor Ramji, MD. Gastroenterology and Hepatology, Division of Gastroenterology, University Of British Columbia. 770-1190 Hornby St. Vancouver, BC. V6Z 2K5.
Valeria Cento, Ph.D. Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Via Montpellier 1, Rome 00133, Italy.
Tanya Applegate, Ph.D. Viral Hepatitis Clinical Research Program. The Kirby Institute, UNSW Sydney. Wallace Wurth Building, Sydney, NSW, 2052. Australia
Jason Grebely, Ph.D. Viral Hepatitis Clinical Research Program. The Kirby Institute, UNSW Sydney. Wallace Wurth Building, Sydney, NSW, 2052 Australia.
Johan Lennerstrand, Ph.D. Clinical Virology, Department of Medical Sciences Uppsala University. Dag Hammarskjölds väg 17, SE-751 85 Uppsala Sweden.
Gary Wang, M.D. Ph.D. (HCV TARGET) Division of Infectious Diseases & Global Medicine, Department of Medicine, University of Florida. 1600 SW Archer Rd, Gainesville, FL 32610, USA.
Charles Boucher, MD. Ph.D. Department of Virology, Rotterdam, Zuid-Holland, Netherlands.
Mark Douglas, MD. Ph.D. Storr Liver Centre, The Westmead Institute for Medical Research, The University of Sydney, NSW, Australia.
Mel Krajden, MD. Ph.D. British Columbia Centre for Disease Control. Vancouver, British Columbia, Canada.
Edward Tam, MD. LAIR Centre, Vancouver, British Columbia, Canada.
David Bonsall MD. PhD. Peter Medawar Building for Pathogen Research, Translational Gastroenterology Unit, Oxford, United Kingdom.
Eleanor Barnes , PhD. Peter Medawar Building for Pathogen Research, Translational Gastroenterology Unit, Oxford, United Kingdom.
Vladimir Chulanov, MD, PhD, DSc. Reference Center for Viral Hepatitis; Central Research Institute of Epidemiology, 3a, Novogireyevskaya str., Moscow, 111123, Russia
Fiona McPhee, Ph.D. Discovery Virology, Bristol-Myers Squibb. 5 Research Parkway, Wallingford, CT, USA. 06492.
Milosz Parczewski, MD PhD, Department of Infectious, Tropical Diseases and Immune Deficiency, Pomeranian Medical University in Szczecin, Arkonska 4, 71-455 Szczecin, Poland.
Jackie Reeve, Ph.D. Virology R&D, Monogram Biosciences, Laboratory Corporation of America Holdings. 345 Oyster Point Blvd., South San Francisco, CA 94080 USA.
Slim Fourati, M.D. Laboratoire de Virologie, Centre National de Référence des Hépatites B, C et delta. INSERM U955. France.
Silvia Bertagnolio, Ph.D. World Health Organization, Geneva, Switzerland.
Rolf Kaiser, Ph.D. Institute of Virology, Univeristy of Cologne. Fuerst-Pueckler-Str. 56, 50935 Cologne, Germany.
Elena Knops, Ph.D. Institut für Virologie, Fürst-Pückler-Str. 56. 50935 Köln.
Anders Lannergård, M.D., PhD. Department of Infectious Diseases, Uppsala University Hospital. S-751 85 Uppsala, Sweden.
Rohit Pai, M.D. Gastroenterology, Vancouver General Hospital, Vancouver, BC Canada.
Oscar Cruz Pereira, M.D. University of British Columbia, BC, Canada.
Samuel Lee, M.D. University of Calgary, AB, Canada. 3330 Hospital Drive NW, Calgary, AB. Canada. T2N 4N1.
Christoph Sarrazin, Ph.D. Universitätsklinikum Frankfurt, D-60590 Frankfurt, Germany
Julia Dietz, Ph.D. Universitätsklinikum Frankfurt, D-60590 Frankfurt.
Louis Welebob, Ph.D. Vela Diagnostics USA Inc., 353C Route 46 West Suite 250 Fairfield, NJ 07004.
Alexander Wong, M.D. Regina General Hospital, 1440 – 14th Avenue, Regina, Saskatchewan, Canada, S4P 0W5.
Vladimir Marquez,Vancouver General Hospital, 2775 Laurel Street, Vancouver, BC Canada V5Z 1M9
Stephanie Popping, MD. PhD. Department of Viroscience, Erasmus University Medical Center, Weytemaweg 80, 3015CN, Rotterdam, The Netherlands
Javier Sfalcin, Ph.D. Laboratorio CIBIC, Zeballos 249 (S2000CXP), Rosario, Argentina.
Perpetua Gomes, Ph.D. Hospital Egas Moniz, Lisbon and CiiEM, Almada, Portugal. (HepCare)
Mario Poljak, M.D., Ph.D. Slovenian HIV/AIDS Reference Centre, Institute of Microbiology and Immunology at Faculty of Medicine, University of Ljubljana, Slovenia (HepCare).
Maja Lunar, Ph.D. University of Ljubljana · Faculty of Medicine (HepCare).
Dominique Salmon, M.D., Ph.D. Université Paris Descartes, Paris, France (HepCare).
Orna Mor, Ph.D. Central Virology Laboratory, Sheba Medical Center, Ramat-Gan, Israel (HepCare).
Carole Seguin-Devaux, Ph.D. Luxembourg Institute of Health, Luxembourg, Luxembourg (HepCare).
Murat Sayan, Ph.D. Clinical Laboratory, Faculty of MedicineKocaeli University Faculty of Medicine, Kocaeli, Turkey (HepCare).
Ana Martínez-Sapiña, M.D. Hospital Miguel Servet, Zaragoza; Spain.
Pilar Rincón, M.D. Hospital Universitario de Valme; Infectious diseases; Seville; Spain.
Carlos Galera, M.D. Hospital Reina Sofia; Infectious diseases; Murcia, Spain
Josep Quer, M.D. Fundació Hospital Universitari Vall d’hebron – Institut de recerca (“VHIR”) and Hospital Universitari Vall d’hebron (HUVH), Barcelona, Spain
Janke Schinkel, M.D., Ph.D. Amsterdam Universitair Medische Centra, AMC. Amsterdam, Netherlands.
Jelle Koopsen, MSc. Amsterdam Universitair Medische Centra, AMC. Amsterdam, Netherlands.